4.3 Article

MAO inhibitors: Risks, benefits, and lore

Journal

CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 77, Issue 12, Pages 859-+

Publisher

CLEVELAND CLINIC
DOI: 10.3949/ccjm.77a.09103

Keywords

-

Funding

  1. Medtronic

Ask authors/readers for more resources

Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available